Tod M - Search Results

1

CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial.

You B, Robelin P, Tod M, Louvet C, Lotz JP, Abadie-Lacourtoisie S, Fabbro M, Desauw C, Bonichon-Lamichhane N, Kurtz JE, Follana P, Leheurteur M, Piano FD, Ferron G, De Rauglaudre G, Ray-Coquard I, Combe P, Chevalier-Place A, Joly F, Leary A, Pujade-Lauraine E, Freyer G, Colomban O. You B, et al. Among authors: tod m. Clin Cancer Res. 2020 Sep 1;26(17):4625-4632. doi: 10.1158/1078-0432.CCR-20-0054. Epub 2020 Mar 24. Clin Cancer Res. 2020. PMID: 32209570 Clinical Trial.

2

Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomy.

You B, Perrin P, Freyer G, Ruffion A, Tranchand B, Hénin E, Paparel P, Ribba B, Devonec M, Falandry C, Fournel C, Tod M, Girard P. You B, et al. Among authors: tod m. Clin Biochem. 2008 Jul;41(10-11):785-95. doi: 10.1016/j.clinbiochem.2008.04.001. Epub 2008 Apr 11. Clin Biochem. 2008. PMID: 18440312

3

Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.

You B, Tranchand B, Girard P, Falandry C, Ribba B, Chabaud S, Souquet PJ, Court-Fortune I, Trillet-Lenoir V, Fournel C, Tod M, Freyer G. You B, et al. Among authors: tod m. Lung Cancer. 2008 Nov;62(2):261-72. doi: 10.1016/j.lungcan.2008.03.008. Epub 2008 Apr 28. Lung Cancer. 2008. PMID: 18442869 Clinical Trial.

4

Prognostic value of modeled PSA clearance on biochemical relapse free survival after radical prostatectomy.

You B, Girard P, Paparel P, Freyer G, Ruffion A, Charrié A, Hénin E, Tod M, Perrin P. You B, et al. Among authors: tod m. Prostate. 2009 Sep 1;69(12):1325-33. doi: 10.1002/pros.20978. Prostate. 2009. PMID: 19475643

5

Population pharmacokinetics and pharmacodynamics of cisplatinum during hyperthermic intraperitoneal chemotherapy using a closed abdominal procedure.

Cotte E, Colomban O, Guitton J, Tranchand B, Bakrin N, Gilly FN, Glehen O, Tod M. Cotte E, et al. Among authors: tod m. J Clin Pharmacol. 2011 Jan;51(1):9-18. doi: 10.1177/0091270009360980. Epub 2010 Feb 19. J Clin Pharmacol. 2011. PMID: 20173087 Clinical Trial.

6

Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.

You B, Fronton L, Boyle H, Droz JP, Girard P, Tranchand B, Ribba B, Tod M, Chabaud S, Coquelin H, Fléchon A. You B, et al. Among authors: tod m. Urology. 2010 Aug;76(2):423-9.e2. doi: 10.1016/j.urology.2010.02.049. Epub 2010 May 15. Urology. 2010. PMID: 20472276

7

Influence of dosing schedule on organ exposure to cyclosporin in pediatric hematopoietic stem cell transplantation: analysis with a PBPK model.

Gérard C, Bleyzac N, Girard P, Freyer G, Bertrand Y, Tod M. Gérard C, et al. Among authors: tod m. Pharm Res. 2010 Dec;27(12):2602-13. doi: 10.1007/s11095-010-0252-1. Epub 2010 Sep 2. Pharm Res. 2010. PMID: 20811933

8

Links between cyclosporin exposure in tissues and graft-versus-host disease in pediatric bone marrow transplantation: analysis by a PBPK model.

Gérard C, Bleyzac N, Girard P, Freyer G, Bertrand Y, Tod M. Gérard C, et al. Among authors: tod m. Pharm Res. 2011 Mar;28(3):531-9. doi: 10.1007/s11095-010-0299-z. Epub 2010 Oct 21. Pharm Res. 2011. PMID: 20963627

9

A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers.

Ribba B, Watkin E, Tod M, Girard P, Grenier E, You B, Giraudo E, Freyer G. Ribba B, et al. Among authors: tod m. Eur J Cancer. 2011 Feb;47(3):479-90. doi: 10.1016/j.ejca.2010.10.003. Epub 2010 Nov 10. Eur J Cancer. 2011. PMID: 21074409

10

Dose adaptation of capecitabine based on individual prediction of limiting toxicity grade: evaluation by clinical trial simulation.

Paule I, Tod M, Hénin E, You B, Freyer G, Girard P. Paule I, et al. Among authors: tod m. Cancer Chemother Pharmacol. 2012 Feb;69(2):447-55. doi: 10.1007/s00280-011-1714-9. Epub 2011 Aug 2. Cancer Chemother Pharmacol. 2012. PMID: 21809035

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters